Waters Groß

Plas­mi­on and Wa­ters – Co-Mar­ke­­ting Agree­ment


Com­pa­nies agree to make Plas­mi­on SICRIT® ion source com­pa­ti­ble with Wa­ters ACQUITY™ QDa™ De­tec­tor and SELECT SERIES™
Cy­clic IMS™ mass spec­tro­me­ters

Augs­burg, Fe­bru­ary 21, 2024 – Plas­mi­on has an­noun­ced it has si­gned a co-mar­ke­ting and co-pro­mo­ti­on agree­ment with Wa­ters Cor­po­ra­ti­on to enhan­ce ana­ly­ti­cal tech­no­lo­gies used in sci­en­ti­fic la­bo­ra­to­ries and Ap­pli­ed Mar­kets, to help
ad­van­ce hu­man he­alth and well-be­ing.

Th­rough their agree­ment, the com­pa­nies have en­su­red com­pa­ti­bi­li­ty of Plasmion’s SICRIT ion source with the Wa­ters ACQUITY™ QDa™ De­tec­tor and SELECT SERIES™ Cy­clic IMS™ mass spec­tro­me­ters to con­tri­bu­te in ad­van­cing re­se­arch in the Ap­pli­ed Mar­kets and Life Sci­en­ces.

Dr. Tho­mas Wolf, CEO of Plas­mi­on:

„Th­rough our joint ac­ti­vi­ties, we will con­tri­bu­te to ad­van­cing re­se­arch and de­ve­lo­p­ment, hel­ping sci­en­tists make es­sen­ti­al ana­ly­ses si­gni­fi­cant­ly simp­ler, fas­ter, and more se­cu­re. Pro­vi­ding simp­le Plug & Play so­lu­ti­ons for Point-of-Need Ana­ly­tics ap­pli­ca­ti­ons makes sci­en­ti­fic tech­no­lo­gy ac­ces­si­ble to a broa­der au­di­ence in the Ap­pli­ed Mar­kets.“

Di­rect Me­a­su­re­ment via SICRIT Ion Source on Wa­ters ACQUITY QDa De­tec­tor

Gary Har­land, Se­ni­or Di­rec­tor and Port­fo­lio Ow­ner, Dis­co­very and De­ve­lo­p­ment, Wa­ters Cor­po­ra­ti­on:

“Com­bi­ning Plasmion’s SICRIT di­rect io­niza­ti­on source with Wa­ters mass spec­tro­me­try in­stru­ments opens many new ana­ly­ti­cal pos­si­bi­li­ties for at-point ap­pli­ca­ti­ons. The­se in­clude pro­cess op­ti­miza­ti­on and pro­cess mo­ni­to­ring, as well as on­line di­rect de­tec­tion of po­ten­ti­al bio­mar­kers in emer­ging are­as of me­ta­bo­lo­mics. It’s a simp­le, ef­fi­ci­ent, and powerful ad­di­ti­on to our in­stru­ments that of­fers cus­to­mers an ad­van­ced tool for real-time ana­ly­sis of che­mi­cal com­pon­ents and bio­me­di­cal samples.”

Wa­ters Sel­ect Se­ries com­pa­ti­ble with Plas­mi­on Breath Mo­du­le

Plasmion’s in­no­va­ti­ve and uni­que io­niza­ti­on tech­no­lo­gy, SICRIT, en­ables users to sim­pli­fy che­mi­cal ana­ly­sis and has the po­ten­ti­al to make mass spec­tro­me­try more ac­ces­si­ble. The uni­que flow-th­rough io­niza­ti­on tech­no­lo­gy fea­tures ana­ly­sis with a broa­der spec­trum of ana­lytes, litt­le to no frag­men­ta­ti­on, and high sen­si­ti­vi­ty.

SICRIT can be cou­pled to Wa­ters in­stru­ments such as ACQUITY QDa De­tec­tor and SELECT SERIES Cy­clic IMS sys­tems and en­ables users to con­duct di­rect mass spec­tro­me­try in a quan­ti­ta­ti­ve man­ner, si­gni­fi­cant­ly spee­ding up ana­ly­sis pro­ces­ses. Among­st other ap­pli­ca­ti­ons, this also en­ables the di­rect ana­ly­sis of hu­man breath for bio­mar­ker dis­co­very. If samples re­qui­re it, SICRIT also al­lows cou­pling with any kind of chro­ma­to­gra­phy (GC, LC, SFC, etc.) to the mass spec­tro­me­ter, pro­vi­ding cus­to­mers with ul­ti­ma­te fle­xi­bi­li­ty.

A tech­ni­cal part­ner­ship with Wa­ters opens new op­por­tu­ni­ties for ad­van­ced che­mi­cal de­tec­tion in Ap­pli­ed Mar­kets and aims to im­pro­ve tech­no­lo­gy for hu­man he­alth and well-be­ing.

About Plas­mi­on

Plas­mi­on, head­quar­te­red in Augs­burg, Ger­ma­ny, stri­ves to sim­pli­fy mass spec­tro­me­try and bridging from la­bo­ra­to­ry pre­cis­i­on to in­dus­tri­al work­flows. Af­ter in­tro­du­cing it to the mar­ket in 2018, their SICRIT tech­no­lo­gy not only re­vo­lu­tio­ni­zes che­mi­cal ana­ly­sis in the lab, but also makes it pos­si­ble to use mass spec­tro­me­ters as au­to­ma­ted VOC sen­sors in in­dus­tri­al en­vi­ron­ments.